Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30. April 2020 INDIZES USA

HOUSTON, April 30, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced equity induce …
(Orginal – Story lesen…)

Tags: dow jones nasdaq s&p 500

You may also like...